A Long-Term Safety and Tolerability Extension Study Evaluating Atogepant for the Prevention of Chronic or Episodic Migraine

Part of paid clinical trials in Phoenix, Arizona.

Sponsor
AbbVie
Study ID
NCT04686136
Phase
PHASE3
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 80 Years
Healthy Volunteers
Not accepted

Interventions

Study Details

This study will evaluate the Long-Term Safety and Tolerability of Atogepant 60 mg daily for the Prevention of Migraine in Participants with Chronic or Episodic Migraine

Key Dates

Start date
Feb 19, 2021
Status verified
Dec 2025
Primary completion
Oct 20, 2025
Completion
Oct 20, 2025

Study Design

Enrollment
596 participants (actual)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Atogepant 60 mg
    Taken once daily

Primary Outcome Measure

Percentage of Participants with at Least 1 Treatment Emergent Adverse Event [ Time Frame: 156 weeks ]

Locations (42)

FacilityCityStateZIPSite coordinators
Duplicate_Barrow Neurological Institute /ID# 228217PhoenixArizona85013-4407-
California Headache and Balance Center /ID# 226241FresnoCalifornia93720-
Duplicate_Pharmacology Research Institute (PRI) - Los Alamitos (Wake) /ID# 226404Los AlamitosCalifornia90720-3500-
Pharmacology Research Institute (PRI) - Newport Beach (Wake) /ID# 226389Newport BeachCalifornia92660-
Excell Research, Inc /ID# 228390OceansideCalifornia92056-
Duplicate_Schuster Medical Research Institute /ID# 226246Sherman OaksCalifornia91403-
Alpine Clinical Research Center /ID# 226203BoulderColorado80301-1880-
Sensible Healthcare /ID# 226426OcoeeFlorida34761-
Accel Research Sites - Tampa Clinical Research Unit /ID# 226252TampaFlorida33634-
NeuroTrials Research Inc /ID# 226477AtlantaGeorgia30342-
Allied Physicians - Fort Wayne Neurological Center /ID# 226390Fort WayneIndiana46804-
Josephson-Wallack-Munshower Neurology - Northeast /ID# 226295IndianapolisIndiana46256-
Collective Medical Research /ID# 226482Overland ParkKansas66210-
Ochsner Clinic Foundation /ID# 228220CovingtonLouisiana70433-8107-
Pharmasite Research, Inc. /ID# 226444BaltimoreMaryland21208-
Beth Israel Deaconess Medical Center /ID# 228214BostonMassachusetts02215-5400-
BTC of New Bedford /ID# 226289New BedfordMassachusetts02740-
Clinical Research Institute, Inc /ID# 226232MinneapolisMinnesota55402-2606-
Headache Neurology Research Institute /ID# 226234RidgelandMississippi39157-
StudyMetrix Research /ID# 226296City of Saint PetersMissouri63303-
Clinvest Research LLC /ID# 226275SpringfieldMissouri65807-
Methodist Physicians Clinic/CCT Research /ID# 226422FremontNebraska68025-
Albuquerque Clinical Trials, Inc. /ID# 226523AlbuquerqueNew Mexico87102-
Albany Medical Center Rheumatology /ID# 228212AlbanyNew York12208-3412-
Headache Wellness Center /ID# 226233GreensboroNorth Carolina27405-
Duplicate_CTI Clinical Research Center /ID# 226278CincinnatiOhio45212-
Stetson-University of Cincinnati /ID# 226326CincinnatiOhio45219-
Abington Neurological Associates - Abington /ID# 226449AbingtonPennsylvania19001-
Preferred Primary Care Physicians, Inc. /ID# 226447PittsburghPennsylvania15236-
Mount Vernon Clinical Research /ID# 226249ChattanoogaTennessee37421-
CNS Healthcare - Memphis /ID# 226254MemphisTennessee38119-
Austin Clinical Trial Partners /ID# 228391AustinTexas78737-
FutureSearch Trials of Neurology /ID# 226424AustinTexas78731-
DiscoveResearch, Inc /ID# 226490BryanTexas77802-
Texas Neurology /ID# 226425DallasTexas75214-
LinQ Research, LLC /ID# 226391PearlandTexas77584-
Highland Clinical Research /ID# 226287Salt Lake CityUtah84124-
J. Lewis Research, Inc. / Foothill Family Clinic /ID# 226248Salt Lake CityUtah84109-
J. Lewis Research, Inc. Foothill Family Clinic South /ID# 226328Salt Lake CityUtah84121-
Sentara Family Medicine Physicians /ID# 226448Virginia BeachVirginia23456-
Northwest Clinical Research Center /ID# 226240BellevueWashington98007-
Puget Sound Neurology /ID# 226253TacomaWashington25328-

Find similar trials in Phoenix, AZ

By condition
By specialty

Related Studies